WEED (BUDZ) 10-K 30 Mar 20 2019 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2019	Mar. 30, 2020	Jun. 30, 2019
Document And Entity Information
Entity Registrant Name	WEED, INC.
Entity Central Index Key	0001393772
Document Type	10-K
Document Period End Date	Dec. 31, 2019
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Well Known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		110,722,685
Entity Public Float			$ 16,651,337
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2019
Entity Interactive Data Current	Yes
Entity Incorporation State Country Code	NV
Entity File Number	000-53727

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2019	Dec. 31, 2018
CURRENT ASSETS:
Cash	$ 2,509	$ 70,608
Accounts receivable	822	21
Prepaid expenses	30,979	71,290
Deposits	92,000	350,020
TOTAL CURRENT ASSETS	126,310	491,939
Land	136,400	136,400
Building	1,887,802	1,887,802
Computers & Equipment	73,681	570,397
Vehicle	0	105,132
Leasehold improvements	5,000	5,000
Property, plant, and equipment gross	2,102,883	2,568,331
Less: Accumulated depreciation	322,498	224,198
Property and equipment, net	1,780,385	2,480,533
Trademark	50,000	50,000
Less: Accumulated amortization	(4,083)	(1,483)
Trademark, net	45,917	48,517
TOTAL ASSETS	1,952,612	3,020,989
CURRENT LIABILITIES
Accounts payable	212,181	240,459
Accrued expense	10,000	0
Accrued officer compensation	122,250	0
Accrued interest	16,453	6,903
Notes payable, related parties	224,100	12,000
Notes payable	167,263	0
Due to officer	723	0
TOTAL CURRENT LIABILITIES	752,970	259,362
TOTAL LIABILITIES	752,970	259,362
STOCKHOLDERS' EQUITY
Common stock, $0.001 par value, 200,000,000 authorized, 109,262,685 and 105,950,685 issued and outstanding,	109,263	105,951
Additional paid-in capital	76,660,712	50,695,721
Subscription payable	356,250	356,250
Accumulated deficit	(75,925,974)	(48,396,295)
Foreign currency translation	(609)	0
TOTAL STOCKHOLDERS' EQUITY	1,199,642	2,761,627
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY	$ 1,952,612	$ 3,020,989

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2019	Dec. 31, 2018
Statement of Financial Position [Abstract]
Common stock, par value	$ .001	$ 0.001
Common stock, authorized	200,000,000	200,000,000
Common stock, issued	109,262,685	105,950,685
Common stock, outstanding	109,262,685	105,950,685

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Income Statement [Abstract]
REVENUE	$ 0	$ 0
OPERATING EXPENSES
General and administrative expenses	969,913	1,358,178
Professional fees	26,287,730	26,866,800
Depreciation & amortization	159,423	180,640
Total operating expenses	27,417,067	28,405,618
NET OPERATING LOSS	(27,417,067)	(28,405,618)
OTHER INCOME (EXPENSE)
Interest income	0	9,338
Interest expense	(11,672)	(12,179)
Other income	1,016	155,701
Loss on deposit	(100,000)	(110,000)
Loss on extinguishment of debt	0	(1,064,720)
Gain on extinguishment of debt	0	121,475
Other expense	(1,956)	(9,004)
TOTAL OTHER EXPENSE, NET	(112,612)	(909,389)
NET LOSS	(27,529,679)	(29,315,007)
OTHER COMPREHENSIVE LOSS	(609)	0
COMPREHENSIVE LOSS	$ (27,530,288)	$ (29,315,007)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES
Outstanding - basic and fully diluted	107,649,127	103,168,018
Net loss per share - basic and fully diluted	$ 0.26	$ (0.28)

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)	Common Stock	Additional Paid-In Capital	Subscription Payable	Accumulated Deficit	Accumulated Other Comprehensive	Total
Beginning balance, shares at Dec. 31, 2017	100,861,235
Beginning balance, amount at Dec. 31, 2017	$ 100,861	$ 19,139,868	$ 200,770	$ (19,081,288)	$ 0	$ 360,211
Common stock sold for cash, shares	3,899,450
Common stock sold for cash, amount	$ 3,900	4,794,651				4,798,551
Common stock issued for cash, exercise of warrants, shares	150,000
Common stock issued for cash, exercise of warrants, amount	$ 150	224,850				225,000
Common stock issued for debt settlement, shares	125,000
Common stock issued for debt settlement, amount	$ 125	1,449,875				1,450,000
Common stock issued for services, shares	915,000
Common stock issued for services, amount	$ 915	3,133,105	155,480			3,089,100
Vesting of employee stock options		21,284,610				21,284,610
Vesting of employee stock compensation		869,162				869,162
Net loss				(29,315,007)		(29,315,007)
Other comprehensive income, net						0
Ending balance, shares at Dec. 31, 2018	105,950,685
Beginning balance, amount at Dec. 31, 2018	$ 105,951	50,896,121	356,250	(48,396,295)	0	2,761,627
Common stock sold for cash, shares	1,065,000
Common stock sold for cash, amount	$ 1,065	571,935				573,000
Common stock returned, shares	(220,000)
Common stock returned, amount	$ (220)	220				0
Common stock issued for services, shares	2,467,000
Common stock issued for services, amount	$ 2,467	2,575,783				2,578,250
Vesting of employee stock options		22,770,662				22,770,662
Related party gain on sale of automobile		46,391				46,391
Net loss				(27,529,679)		(27,529,679)
Other comprehensive income, net					(609)	(609)
Ending balance, shares at Dec. 31, 2019	109,262,685
Beginning balance, amount at Dec. 31, 2019	$ 109,263	$ 76,660,712	$ 356,250	$ (75,925,974)	$ (609)	$ 1,199,642

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (27,529,679)	$ (29,315,007)
Adjustments to reconcile net loss used in operating activities:
Depreciation and amortization	159,423	180,640
Gain on settlement of debt	0	(121,475)
Loss on deposit	0	110,000
Impairment of CIP	499,695	321,614
Estimated fair value of stock based compensation	22,770,662	21,201,397
Estimated fair value of shares issued for services	2,578,250	4,041,575
Loss on debt extinguishment	0	1,064,720
Decrease (increase) in assets
Accounts receivable	(801)	(21)
Prepaid expenses and other assets	298,331	(498,311)
Increase (decrease) in liabilities
Accounts payable	(28,278)	11,849
Accrued expenses	141,800	(178,335)
NET CASH USED IN OPERATING ACTIVITIES	(1,110,597)	(3,181,303)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property and equipment	(2,979)	(826,481)
Purchase of intangible assets	0	(50,000)
NET CASH USED IN INVESTING ACTIVITIES	(2,979)	(876,481)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from notes payable - related party	305,823	7,000
Proceeds from the sale of common stock	573,000	5,023,401
Proceeds from notes payable	250,850	0
Repayments on notes payable	(83,587)	(1,063,187)
NET CASH PROVIDED BY FINANCING ACTIVITIES	1,046,086	3,967,214
NET CHANGE IN CASH	(67,490)	(90,570)
CASH, BEGINNING OF YEAR	70,608	161,178
CASH, END OF YEAR	2,509	70,608
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Income taxes	0	0
Interest paid	0	0
Non-cash investing and financing activities:
Gain on related party transaction	93,000	0
Mortgage issued for acquisition of land and property	0	1,040,662
Shares issued for subscription payable	0	200,770
Value of shares issued to pay off note payable	$ 0	$ 385,281

Nature of Business and Signific

Nature of Business and Significant Accounting Policies	12 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
Nature of Business and Significant Accounting Policies	Nature of Business WEED, Inc. (the “Company”), (formerly United Mines, Inc.) was incorporated under the laws of the State of Arizona on August 20, 1999 (“Inception Date”) as Plae, Inc. to engage in the exploration of gold and silver mining properties. On November 26, 2014, the Company was renamed from United Mines, Inc. to WEED, Inc. and was repurposed to pursue a business involving the purchase of land, and building Commercial Grade “Cultivation Centers” to consult, assist, manage & lease to Licensed Dispensary owners and organic grow operators on a contract basis, with a concentration on the legal and medical marijuana sector. The Company’s plan is to become a True “Seed-to-Sale” company providing infrastructure, financial solutions and real estate options in this new emerging market. The Company, under United Mines, was formerly in the process of acquiring mineral properties or claims located in the State of Arizona, USA. The name was previously changed on February 18, 2005 to King Mines, Inc. and then subsequently changed to United Mines, Inc. on March 30, 2005. The Company trades on the OTC Pink Sheets under the stock symbol: BUDZ. On April 20, 2017, the Company acquired Sangre AT, LLC, a Wyoming company doing business as Sangre AgroTech. (“Sangre”). Sangre is a plant genomic research and breeding company comprised of top-echelon scientists with extensive expertise in genomic sequencing, genetics-based breeding, plant tissue culture, and plant biochemistry, utilizing the most advanced sequencing and analytical technologies and proprietary bioinformatics data systems available. No work is being conducted now until further funds are available. The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America. These statements reflect all adjustments, consisting of normal recurring adjustments, which in the opinion of management are necessary for fair presentation of the information contained therein. The Company has a calendar year end for reporting purposes. Basis of Presentation: The accompanying condensed consolidated balance sheet at December 31, 2019, has been derived from audited consolidated financial statements and the unaudited condensed consolidated financial statements as of June 30, 2019 and 2018 ( the “financial statements”), have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements and should be read in conjunction with the audited consolidated financial statements and related footnotes included in our Registration Statement on Form S-1 for the year ended December 31, 2019 (the “2019 Annual Report”), filed with the Securities and Exchange Commission (the “SEC”). It is management’s opinion, however, that all material adjustments (consisting of normal recurring adjustments), have been made which are necessary for a fair financial statements presentation. The condensed consolidated financial statements include all material adjustments (consisting of normal recurring accruals) necessary to make the condensed consolidated financial statements not misleading as required by Regulation S-X, Rule 10-01. Principles of Consolidation The accompanying consolidated financial statements include the accounts of the following entities, all of which are under common control and ownership: State of Abbreviated Name of Entity Incorporation Relationship (1) Reference WEED, Inc. Nevada Parent WEED Sangre AT, LLC (2) Wyoming Subsidiary Sangre (1) Sangre is a wholly-owned subsidiary of WEED, Inc. (2) Sangre AT, LLC is doing business as Sangre AgroTech. The consolidated financial statements herein contain the operations of the wholly-owned subsidiary listed above. All significant inter-company transactions have been eliminated in the preparation of these financial statements. The parent company, WEED and subsidiary, Sangre will be collectively referred to herein as the “Company”, or “WEED”. The Company’s headquarters are located in Tucson, Arizona and its operations are primarily within the United States, with minimal operations in Australia. These statements reflect all adjustments, consisting of normal recurring adjustments, which in the opinion of management are necessary for fair presentation of the information contained therein. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Fair Value of Financial Instruments Under FASB ASC 820-10-05, the Financial Accounting Standards Board establishes a framework for measuring fair value in generally accepted accounting principles and expands disclosures about fair value measurements. This Statement reaffirms that fair value is the relevant measurement attribute. The adoption of this standard did not have a material effect on the Company’s financial statements as reflected herein. The carrying amounts of cash, prepaid expenses and accrued expenses reported on the balance sheet are estimated by management to approximate fair value primarily due to the short term nature of the instruments. Impairment of Long-Lived Assets Long-lived assets held and used by the Company are reviewed for possible impairment whenever events or circumstances indicate the carrying amount of an asset may not be recoverable or is impaired. Recoverability is assessed using undiscounted cash flows based upon historical results and current projections of earnings before interest and taxes. Impairment is measured using discounted cash flows of future operating results based upon a rate that corresponds to the cost of capital. Impairments are recognized in operating results to the extent that carrying value exceeds discounted cash flows of future operations. Basic and Diluted Loss Per Share The basic net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding. Diluted net loss per common share is computed by dividing the net loss adjusted on an “as if converted” basis, by the weighted average number of common shares outstanding plus potential dilutive securities. For the periods presented, potential dilutive securities had an anti-dilutive effect and were not included in the calculation of diluted net loss per common share. Stock-Based Compensation Under FASB ASC 718-10-30-2, all share-based payments to employees, including grants of employee stock options, to be recognized in the income statement based on their fair values. Pro forma disclosure is no longer an alternative. Revenue Recognition On January 1, 2018, the Company adopted the new revenue recognition standard ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)”, using the cumulative effect (modified retrospective) approach. Modified retrospective adoption requires entities to apply the standard retrospectively to the most current period presented in the financial statements, requiring the cumulative effect of the retrospective application as an adjustment to the opening balance of retained earnings at the date of initial application. No cumulative-effect adjustment in retained earnings was recorded as the Company’s has no historical revenue. The impact of the adoption of the new standard was not material to the Company’s condensed consolidated financial statements for the year ended December 31, 2019. The Company expects the impact to be immaterial on an ongoing basis. The primary change under the new guidance is the requirement to report the allowance for uncollectible accounts as a reduction in net revenue as opposed to bad debt expense, a component of operating expenses. The adoption of this guidance did not have an impact on our condensed consolidated financial statements, other than additional financial statement disclosures. The guidance requires increased disclosures, including qualitative and quantitative disclosures about the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The Company operates as one reportable segment. Sales on fixed price contracts are recorded when services are earned, the earnings process is complete or substantially complete, and the revenue is measurable and collectability is reasonably assured. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. The Company will defer any revenue from sales in which payment has been received, but the earnings process has not occurred. Sales have not yet commenced. Advertising and Promotion All costs associated with advertising and promoting products are expensed as incurred. These expenses were $3,450 and $998 for the years ended December 31, 2019 and 2018. Recently Issued Accounting Pronouncements In August 2018, the FASB issued ASU 2018-15 Accounting for Implementation Costs Related to Cloud Computing or Hosting Arrangements. This standard provides authoritative guidance intended to address a customer’s accounting for implementation costs incurred in a cloud computing arrangement that is a service contract. This guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The guidance also requires presentation of the capitalized implementation costs in the statement of financial position and in the statement of cash flows in the same line item that a prepayment for the fees of the associated hosting arrangement would be presented, and the expense related to the capitalized implementation costs to be presented in the same line item in the statement of operations as the fees associated with the hosting element (service) of the arrangement. This guidance is effective for annual periods beginning after December 15, 2019, including interim periods within those annual periods, with early adoption permitted. We are currently evaluating the potential impact on our financial position, results of operations and statement of cash flows upon adoption of this guidance. We do not expect this guidance to have a significant impact, or potential significant impact, to our unaudited condensed consolidated interim financial statements. In February 2016, the FASB issued ASU 2016-02, Leases. The standard requires lessees to recognize lease assets and lease liabilities on the consolidated balance sheet and requires expanded disclosures about leasing arrangements. We plan to adopt the standard on January 1, 2019. We are currently assessing the impact that the new standard will have on our consolidated financial statements, which will consist primarily of a balance sheet gross up of our operating leases to show equal and offsetting lease assets and lease liabilities. The Company adopted the new lease guidance effective January 1, 2019 using the modified retrospective transition approach, applying the new standard to all of its leases existing at the date of initial application which is the effective date of adoption. Consequently, financial information will not be updated and the disclosures required under the new standard will not be provided for dates and periods before January 1, 2019. We elected the package of practical expedients which permits us to not reassess (1) whether any expired or existing contracts are or contain leases, (2) the lease classification for any expired or existing leases, and (3) any initial direct costs for any existing leases as of the effective date. We did not elect the hindsight practical expedient which permits entities to use hindsight in determining the lease term and assessing impairment. The adoption of the lease standard did not change our previously reported consolidated statements of operations and did not result in a cumulative catch-up adjustment to opening equity. As of December 31, 2019, the adoption of the standard had no impact on the Company, as there were no leases in place longer than 12 months. In June 2018, the FASB issued Accounting Standards Update (“ASU”) 2018-07, Compensation – Stock Compensation (Topic 718) Improvements to Nonemployee Share-Based Payment Accounting

Going Concern

Going Concern	12 Months Ended
	Dec. 31, 2019
Going Concern
Going Concern	As shown in the accompanying financial statements, the Company has no revenues, incurred net losses from operations resulting in an accumulated deficit of $75,925,974 and negative working capital of 626,660 at December 31, 2019. These factors raise substantial doubt about the Company’s ability to continue as a going concern. Management is actively pursuing new products and services to begin generating revenues. In addition, the Company is currently seeking additional sources of capital to fund short term operations. The Company, however, is dependent upon its ability to secure equity and/or debt financing and there are no assurances that the Company will be successful; therefore, without sufficient financing it would be unlikely for the Company to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of any uncertainty as to the Company’s ability to continue as a going concern. The financial statements also do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern.

Related Party

Related Party	12 Months Ended
	Dec. 31, 2019
Related Party Transactions [Abstract]
Related Party	Notes Payable From time to time, the Company has received short term loans from officers and directors as disclosed in Note 7 below. The Company has a total of $224,100 and $12,000 of note payable on the consolidated balance sheet as of December 31, 2019 and 2018, respectively. During the year ended December 31, 2019, the Company transferred the ownership of the 2017 Audi Q7 and Audi A4, valued at $46,609, to Nicole Breen as a repayment for her loans. $93,000 was recorded as a forgiveness on notes payable, and $46,391 recorded to additional paid-in capital. Services Nicole M. Breen receives $1,500 a week in cash compensation for her services rendered to the Company. Glenn E. Martin receives $8,000 a month in cash compensation for his services rendered to the Company. Capital Contributions The Company imputed interest on non-interest bearing, related party loans, resulting in a total of $0 and $0 of contributed capital during the years ended December 31, 2019 and 2018, respectively. Common Stock Issued for Bartered Assets On January 18, 2017, the Company exchanged 66,000 units, consisting of 66,000 shares of common stock and warrants to purchase 66,000 shares of common stock at an exercise price of $3.00 per share, exercisable until January 18, 2018, in exchange for a 2017 Audi Q7 and a 2017 Audi A4 driven by the Officers. The total fair value received, based on the market price of the stock at $4.02 per share, was allocated to the $105,132 purchase price of the vehicles and the $160,188 excess value of the common stock and warrants was expensed as stock-based compensation. During the year ended December 31, 2019, the Company transferred the ownership of the two Audi vehicles, valued at $46,609, to Nicole Breen as a repayment for her loans. $93,000 was recorded as a forgiveness on notes payable, and $46,391 recorded to additional paid-in capital. Common Stock On August 1, 2017, the Company granted 150,000 shares of common stock to Mary Williams, a principal of Sangre AT, LLC, for services performed. The fair value of the common stock was $154,500 based on the closing price of the Company’s common stock on the date of grant. On January 7, 2017, the Company granted 50,000 shares of common stock to Pat Williams. PhD, a principal of Sangre AT, LLC, for services performed. The total fair value of the common stock was $210,250 based on the closing price of the Company’s common stock on the date of grant. A total of $122,250 and $0 of officer compensation was unpaid and outstanding at December 31, 2019 and 2018, respectively. Stock Options Issued for Services – related party (2019) On February 1, 2018, in connection with executive employment agreements, the Company granted non-qualified options to purchase an aggregate of 6,000,000 shares of the Company’s common stock at the exercise price of $10.55 per share. The options shall become exercisable at the rate of 1/3 upon the six-month anniversary, 1/3 upon the one-year anniversary and 1/3 upon the second anniversary of the grant. The options were valued at $45,987,970 using the Black-Scholes option pricing model. The Company recognized expense of approximately, $15,329,323 relating to these options for the year ended December 31, 2019.

Fair Value of Financial Instrum

Fair Value of Financial Instruments	12 Months Ended
	Dec. 31, 2019
Financial Instruments, Owned, at Fair Value [Abstract]
Fair Value of Financial Instruments	Under FASB ASC 820-10-5, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). The standard outlines a valuation framework and creates a fair value hierarchy in order to increase the consistency and comparability of fair value measurements and the related disclosures. Under GAAP, certain assets and liabilities must be measured at fair value, and FASB ASC 820-10-50 details the disclosures that are required for items measured at fair value. The Company has certain financial instruments that must be measured under the new fair value standard. The Company’s financial assets and liabilities are measured using inputs from the three levels of the fair value hierarchy. The three levels are as follows: Level 1 - Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. Level 2 - Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates, yield curves, etc.), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs). Level 3 - Unobservable inputs that reflect our assumptions about the assumptions that market participants would use in pricing the asset or liability. The following schedule summarizes the valuation of financial instruments at fair value on a recurring basis in the balance sheets as of December 31, 2019 and 2018, respectively: Fair Value Measurements at December 31, 2018 Level 1 Level 2 Level 3 Assets Cash $ 70,608 $ - $ - Total assets $ 70,608 $ - $ - Liabilities Notes payable, related parties Notes payable $ - $ 12,000 $ - Total liabilities $ - $ 12,000 $ - $ 70,608 $ 12,000 $ - Fair Value Measurements at December 31, 2019 Level 1 Level 2 Level 3 Assets Cash $ 2,509 $ - $ - Total assets $ 2,509 $ - $ - Liabilities Notes payable, related parties $ 224,100 Notes payable $ - $ 167,263 $ - Total liabilities $ - $ 391,363 $ - $ 2,509 $ 391,363 $ - The fair values of our related party debts are deemed to approximate book value and are considered Level 2 inputs as defined by ASC Topic 820-10-35. There were no transfers of financial assets or liabilities between Level 1, Level 2 and Level 3 inputs for the years ended December 31, 2019 and 2018, respectively.

Investment in Land and Property

Investment in Land and Property	12 Months Ended
	Dec. 31, 2019
Investments [Abstract]
Investment in Land and Property	On July 26, 2017, the Company closed on the purchase of property, consisting of a home, recreational facility and RV park located at 5535 State Highway 12 in La Veta, Colorado to be developed into a bioscience center. The home has 4 Bedrooms and 2 Baths, and the recreational facility has showers, laundry, and reception area with an additional equipment barn attached, in addition to another facility with 9,500 square feet. The RV Park has 24 sites with full hook-ups including water, sewer, and electric, which the Company plans to convert into a series of small research pods. Under the terms of the purchase agreement, the Company paid $525,000 down, including 25,000 shares of our common stock, and Sangre took immediate possession of the property. Under the terms of the original purchase agreement, the Company was obligated to pay an additional $400,000 in cash and issue an additional 75,000 shares of our common stock over the next two years in order to pay the entire purchase price. On January 12, 2018, the Company entered into an Amendment No. 1 to the $475,000 principal amount promissory note issued by the Company to the seller of the property, under which both parties agreed to amend the purchase and the promissory note to allow the Company to pay off the note in full if it paid $100,000 in cash on or before January 15, 2018 and issued the seller 125,000 shares of common stock, restricted in accordance with Rule 144, on before January 20, 2018. Through an escrow process, the Company paid the seller $100,000 in cash and issued him 125,000 shares of common stock in accordance with the Amendment No. 1, in exchange for a full release of the deed of trust that was securing the promissory note, on January 17, 2018. As a result, the $475,000 principal promissory note issued to the seller was deemed paid-in-full and fully satisfied and the Company owned the property without encumbrances as of that date. The Company recorded a loss on extinguishment of debt of approximately $1,065,000 based on the fair value of the consideration paid and the carrying value of the note payable on the settlement date. The total purchase price was as follows: July 26, 2017 Consideration: Common stock payment of 25,000 shares (1) $ 30,000 Cash payment of down payment 50,000 Cash paid at closing 44,640 Short term liabilities assumed and paid at closing (2) 5,360 Note payable (3) 475,000 Total purchase price $ 1,005,000 (1) Consideration consisted of an advance payment of 25,000 shares of the Company’s common stock valued at $30,000 based on the closing price of the Company’s common stock on the July 18, 2017 date of grant. (2) Purchaser’s shares of closing costs, including the seller’s prepaid property taxes. (3) As noted above, the note was settled with a payment of $100,000 and the issuance of 125,000 shares of common stock. In January 2018, the Company closed on the purchase of property, consisting of a condominium in La Veta, Colorado to house Company personnel and consultants for total consideration approximating $140,000, which was paid in cash at the time of closing. The home has 3 bedrooms and 2.5 baths. Sangre took immediate possession of the property. La Veta, Colorado is a small town and rental or short-term housing is very difficult to obtain. The Company personnel and consultants are no longer residing at the property, and it is currently vacant. In February 2018, the Company closed on the purchase of property, consisting of a home in La Veta, Colorado to house Company personnel and consultants for total consideration approximating $1,200,000. The home has 5 Bedrooms and 3 Baths. Under the terms of the purchase agreement, the Company paid $150,000 down, entered into a note payable in the amount of approximately $1,041,000 (see Note 8). The Company secured a below-market interest rate of 1.81% based on the short-term nature of the term (due on August 15, 2018). Sangre took immediate possession of the property. La Veta, Colorado is a small town and rental or short-term housing is very difficult to obtain. The Company personnel and consultants are no longer residing at the property, and it is currently vacant. On October 10, 2018, a payment of $750,000 was made to Craig W. Clark to pay off the note payable, and a loan discount of $125,475 was given to the Company which was recorded as a gain. A settlement payment of $155,000 was received from an insurance company related to a fire near one of our properties in La Veta, Colorado. On June 25, 2019, the Company received $60,000 from Lex Seabre in exchange for 120,000 shares of common stock of the Company. The $60,000 was paid as a deposit for the Sugar Hill golf course property auction. On June 28, 2019, the Company received a loan of $12,000 from Nicole Breen. The $12,000 was paid as a deposit for the Sugar Hill golf course property auction. On September 25, 2019, the Company received $20,000 from Lex Seabre in exchange for 100,000 shares of common stock of the Company. The $20,000 was paid as a deposit for the additional 60-day extension for the Sugar Hill golf course property purchase.

Property and Equipment

Property and Equipment	12 Months Ended
	Dec. 31, 2019
Property, Plant and Equipment [Abstract]
Property and Equipment	Property and equipment consist of the following at December 31, 2019 and 2018, respectively: December 31, December 31, 2019 2018 Property improvements $ 5,000 $ 5,000 Automobiles 0 105,132 Office equipment 4,933 4,933 Furniture & Fixtures 2,979 0 Lab equipment 65,769 65,769 Construction in progress 0 499,695 Property (1) 1,887,802 1,887,802 Property and equipment, gross 1,966,483 2,568,331 Less accumulated depreciation (322,498 ) (224,198 ) Property and equipment, net $ 1,643,985 2,344,133 (1) In 2018, the Company purchased two properties in La Veta, Colorado. The property located on 169 Valley Vista was purchased for $140,000, and the property located on 1390 Mountain Valley Road was purchased for $1,200,000 (see Note 8). Depreciation and amortization expense totaled $159,424 and $180,640 for the years ended December 31, 2019 and 2018, respectively. During the year ended December 31, 2019, the Company transferred the ownership of the 2017 Audi Q7 and Audi A4, valued at $46,609, to Nicole Breen as a repayment for her loans. $93,000 was recorded as a forgiveness on notes payable, and $46,391 recorded to additional paid-in capital. Construction in progress in the amount of $499,695 was fully impaired due to the Company may not receive funds to complete the research facility center project. There was no work performed in 2019.

Intangible Assets

Intangible Assets	12 Months Ended
	Dec. 31, 2019
Intangible Assets, Net (Including Goodwill) [Abstract]
Intangible Assets	In accordance with FASB ASC 350, “Intangibles-Goodwill and Other”, the Company evaluates the recoverability of identifiable intangible assets whenever events or changes in circumstances indicate that an intangible asset’s carrying amount may not be recoverable. The impairment loss would be calculated as the amount by which the carrying value of the asset exceeds its fair value. The US and Europe trademarks were acquired for $40,000 and $50,000, respectively, for the year ended December 31, 2018. Trademarks are initially measured based on their fair value and amortized by 10 and 25 years. Amortization expense totaled $2,600 and $1,483 for the years ended December 31, 2019 and 2018, respectively.

Notes Payable, Related Parties

Notes Payable, Related Parties	12 Months Ended
	Dec. 31, 2019
Notes Payable [Abstract]
Notes Payable, Related Parties	Notes payable, related parties consist of the following at December 31, 2019 and 2018, respectively: December 31, 2019 December 31, 2018 On April 12, 2010, the Company received an unsecured, non-interest-bearing loan in the amount of $2,000, due on demand from Robert Leitzman. Interest is being imputed at the Company’s estimated borrowing rate, or 10% per annum. The largest aggregate amount outstanding was $2,000 during the periods ended December 31, 2019 and December 31, 2018. Mr. Leitzman owns less than 1% of the Company’s common stock, however, the Mr. Leitzman is deemed to be a related party given the non-interest-bearing nature of the loan and the materiality of the debt at the time of origination. 2,000 2,000 Over various dates in 2011 and 2012, the Company received unsecured loans in the aggregate amount of $10,000, due on demand, bearing interest at 10%, from Sandra Orman. The largest aggregate amount outstanding was $10,000 during the periods ended December 31, 2019 and December 31, 2018. Mrs. Orman owns less than 1% of the Company’s common stock, however, Mrs. Orman is deemed to be a related party given the nature of the loan and the materiality of the debt at the time of origination. 10,000 10,000 Over various dates from April to December 2019, the company received a total of $305,100 of advances, bearing interest at 5%, from Nicole Breen. A detailed list of advances and repayments follows. On October 28, 2019, the company’s vehicles valued at $93,000 were used as a repayment. 212,100 0 Notes payable, related parties $ 224,100 $ 12,000 The Company recorded interest expense in the amount of $9,264 and $12,179 for the years ended December 31, 2019 and 2018, respectively, including imputed interest expense in the amount of $0 and $0 during such periods related to notes payable, related parties.

Notes Payable

Notes Payable	12 Months Ended
	Dec. 31, 2019
Notes Payable [Abstract]
Notes Payable	Note payable consist of the following at December 31, 2019 and 2018, respectively: December 31, 2019 December 31, 2018 On July 26, 2017, the Company issued a $475,000 note payable, bearing interest at 5% per annum, to A.R. Miller (“Miller Note”) pursuant to the purchase of land and property in La Veta, Colorado. The note is to be paid in four consecutive semi-annual installments in the amount of $118,750 plus accrued interest commencing on January 26, 2018 and continuing on the 26th day of July and the 26th day of January each year until the debt is repaid on July 26, 2019. The note carries a late fee of $5,937.50 in the event any installment payment is more than 30 days late, and upon default the interest rate shall increase to 12% per annum. During the three months ended March 31, 2018, the Company issued 125,000 shares of common stock, valued at $1,450,000 based on the closing price on the measurement date. Accordingly, the Company recorded a loss on extinguishment of $1,064,719. $ - $ - On February 16, 2018, the Company issued a $1,040,662 note payable, bearing interest at 1.81% per annum (the low interest rate was due to the short-term nature of the note – six months. See Note 6), to Craig and Carol Clark (“Clark Note”) pursuant to the purchase of land and property in La Veta, Colorado. The note is to be paid in consecutive monthly installments in the amount of $5,000, including accrued interest commencing on March 15, 2018 and continuing through August 15, 2018. The note carries a late fee of 3% in the event any installment payment is more than 10 days late, and upon default the interest rate shall increase to 10% per annum. As of September 12, 2018, a total of $171,300 was paid to the note holder. On October 9, 2018, the Company entered into a settlement agreement with the note holder to pay the settlement payment of $750,000. The Company had already paid $650,000 by September 27, 2018 and made the remaining payment of $100,000 on October 10, 2018. The Company recorded a gain on extinguishment of $121,475. On August 5, 2019, the Company entered into a promissory note, whereby the Company promises to pay Snell & Wilmer L.L.P the principal amount of $250,000, bearing interest at 2.5% per annum. The note is to be paid in consecutive monthly installments in the amount of $25,000, including accrued interest commencing on August 30, 2019, until the final balloon payment is paid on January 30, 2020. The promissory note is secured by the Deed of Trust, Assignment of Leases and Rents, Security Agreement and Fixture Filing with respect to the real property owned by Sangre located on 1390 Mountain Valley Road, La Veta, Colorado 81055. As of December 31, 2019, $83,588 has been paid to Snell & Wilmer. $ 166,412 On various dates, the Company received advances from consultant, Patrick Brodnik, bearing 0% interest. $ 850 $ 167,262 $ - The Company recognized interest expense of $2,408 and $0 related to the note payables for the year ended December 31, 2019 and 2018, respectively.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	On November 8, 2016, the Company entered into an agreement with Gregory DiPaolo’s Pro Am Golf, LLC to acquire improved property located in Westfield, New York. The total purchase price of $1,600,000 is to be paid with a deposit of 50,000 shares of common stock, followed by cash of $1,250,000 and 300,000 shares of the Company’s common stock to be delivered at closing. The deposit of 50,000 shares issued as a deposit was $42,500 based on the closing price of the Company’s common stock on the date of grant. Subsequently, we entered into an amended Purchase and Sale Agreement on October 24, 2017, under which we amended the total purchase price to Eight Hundred Thousand Dollars ($800,000) and forfeited our previous deposit of stock. Under the terms of the amended agreement, we paid an additional Ten Thousand Dollar ($10,000) deposit on October 26, 2017, with the remaining purchase price to be paid on or before the date closing date, which was scheduled on May 1, 2018. The property is approximately 43 acres and has unlimited water extraction rights from the State of New York. We had planned to use this property as our inroads to the New York hemp and infused beverage markets in the future. Since the property was in foreclosure it was put up for auction, which occurred on July 1, 2019. At the auction, we were the winning bidder with a bid of $597,000. Our prior deposit payment of $120,000 was credited towards the purchase price, and the remaining $477,000, was finally due on November 30, 2019, after several extensions (which cost us total of $40,000 to obtain). At the end of December 31, 2019, a total of $92,00 was issued as a deposit for the property. We were not able to meet that deadline, but in January 2020 we worked out an additional extension with the bank. Under the terms of the new agreement, we still owe approximately $392,000 to acquire the property. We have agreed to pay that amount in installment payments of $10,000 per month for six months beginning February 2020, with a balloon payment of approximately $332,000 due on or before August 3, 2020. To date we have paid the $10,000 payments for February 2020 and March 2020, and plan to pay the April 2020 payment on time. We need to raise funds in order to make the remaining scheduled payments. On January 19, 2018, the Company was sued in the United States District Court for the District of Arizona ( William Martin v. WEED, Inc.. . Travis Nelson v. Sangre AgroTech, LLC, et al. (Huerfeno County Colorado District Court, Case No. 2018CV30003, filed on February 5, 2018). Mr. Travis Nelson, formerly a member of the subsidiary Sangre AgroTech, LLC, filed this action alleging wrongful discharge in retaliation for whistleblower activity purportedly related to insider trading, fraud and unlawful interstate transportation of plant genetics. After a motion to dismiss was granted in part, Mr. Nelson filed a second amended complaint asserting revised claims for breach of fiduciary duty, wrongful discharge, and violation of the Colorado organized crime control act. Mr. Nelson has alleged lost wages in the amount of $600,000, unspecified losses related to whistleblower allegations, plus costs and attorneys’ fees. In his initial disclosures, Mr. Nelson alleges damages of $10,000,000. On January 31, 2019, Mr. Nelson submitted an offer of judgement in the amount of $100,000. That offer was rejected by the Corporation. Court-ordered mediation was conducted on April 24, 2019, but the matter was not resolved. By order dated February 4, 2020, the court scheduled trial for October 5, 2020. The Corporation denies liability as to all claims. Inasmuch as an unfavorable outcome is neither probable nor remote within the meaning of the ABA Statement of Policy referred to in the last paragraph of this letter, we decline to express an opinion concerning the likely outcome of this matter or the liability of the Corporation, if any, associated therewith. Material Definitive Agreements On May 1, 2018, the Company entered into a Fourth Addendum and Fifth Addendum to that certain Purchase and Sale Agreement between the Company and Greg DiPaolo’s Pro Am Golf, LLC, amending the “Closing Date” under the Agreement to August 1, 2018, in exchange for the Company paying $50,000 as a non-refundable deposit to be applied against the purchase price once the property sale is completed and $10,000 for maintenance, tree removal and other grounds keeping in order to prepare the golf course for the 2018 season. On July 23, 2018, the Company entered into a Sixth Addendum, extending the “Closing Date” to November 1, 2018, in exchange for the Company paying an additional $50,000 as a non-refundable deposit to be applied against the purchase price. On July 1, 2019, the Greg DiPaolo’s Pro Am Golf, LLC property was in foreclosure, and it was put up for auction. At the auction, we were the winning bidder with a bid of $597,000. Our prior deposit payment of $120,000 was credited towards the purchase price, and the remaining $477,000, was finally due on November 30, 2019, after several extensions (which cost us total of $40,000 to obtain). At the end of December 31, 2019, a total of $92,000 was issued as a deposit for the property. We were not able to meet that deadline, but in January 2020 we worked out an additional extension with the bank. Under the terms of the new agreement, we still owe approximately $392,000 to acquire the property. We have agreed to pay that amount in installment payments of $10,000 per month for six months beginning February 2020, with a balloon payment of approximately $332,000 due on or before August 3, 2020. To date we have paid the $10,000 payments for February 2020 and March 2020, and plan to pay the April 2020 payment on time. We need to raise funds in order to make the remaining scheduled payments. On May 21, 2018, the Company entered into a Trademark Purchase Agreement with Copalix Pty Ltd., a private South African company, to acquire U.S. Trademark Registration No. 4,927,872 for the WEED TM mark, in exchange for USD$40,000. On July 27, 2018, the Company entered into a Trademark Purchase Agreement with Copalix Pty Ltd., to acquire European Community Trademark Registration No. 11953387 for WEED Registered Mark in exchange for USD$10,000.

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2019
STOCKHOLDERS' EQUITY
Stockholders' Equity	Preferred Stock On December 5, 2014, the Company amended the Articles of Incorporation, pursuant to which 20,000,000 shares of “blank check” preferred stock with a par value of $0.001 were authorized. No series of preferred stock has been designated to date. Common Stock On December 5, 2014, the Company amended the Articles of Incorporation, and increased the authorized shares to 200,000,000 shares of $0.001 par value common stock. 2019 Common Stock Activity Common Stock Sales (2019) During the year ended December 31, 2019, the Company issued 1,065,000 shares of common stock for proceeds of $573,000. Common Stock Issued for Services (2019) During the year ended December 31, 2019, the Company agreed to issue an aggregate of 2,467,000 shares of common stock to consultants for services performed. The total fair value of common stock was $2,578,250 based on the closing price of the Company’s common stock earned on the measurement date. Shares valued at $121,650 were issued during the year ended December 31, 2019 and services will be performed in 2020 and has been included in unamortized stock-based compensation. Common Stock Cancellations During the year ended December 31, 2019, the Company cancelled a total of 220,000 shares of common stock valued at $0 previously granted to consultants, David Johnson, and Avigor Gordon, for non-performance of services. The cancellation was accounted as a repurchase for no consideration. 2018 Common Stock Activity Common Stock Sales (2018) During the year ended December 31, 2018, the Company issued 3,899,450 shares of common stock for proceeds of $4,798,550. In connection with certain of the share issuances, the Company issued warrants to purchase an aggregate of $1,927,500 shares of the Company’s common stock. The warrants to purchase 462,500 shares have an exercise price of $5.00 per share, exercisable on various dates through March 2019. Warrants to purchase 215,000 shares have an exercise price of $12.50 per share and are exercisable on various dates through January 2020. The warrants to purchase $1,250,000 shares have an exercise price of $6.00 per share, exercisable on various dates through June 2019. The proceeds received were allocated $3,361,832 to common stock and $1,436,718 to warrants on a relative fair value basis. On January 12, 2018, a warrant holder exercised warrants to purchase 150,000 shares of common stock at a price of $1.50 in exchange for proceeds of $225,000. Common Stock Issued for Services (2018) During the year ended December 31, 2018, the Company agreed to issue an aggregate of 915,000 shares of common stock to consultants for services performed. The total fair value of common stock was $3,042,940 based on the closing price of the Company’s common stock earned on the measurement date. Shares valued at $200,400 were issued at December 31, 2018 and services will be performed in 2019 and has been included in unamortized stock-based compensation.

Common Stock Warrants and Optio

Common Stock Warrants and Options	12 Months Ended
	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Common Stock Warrants and Options	Common Stock Warrants Granted (2019) No common stock warrants were granted during the year ended December 31, 2019. Common stock warrants granted consist of the following at December 31, 2019 and 2018, respectively: 2019 2018 Issuance Warrant # of Common Issuance Warrant # of Common Date # Name Stock Warrants Date # Name Stock Warrants 1/5/2018 1029 Lex Seabre 100,000.00 Total - 1/21/2018 1031 Roger Forsyth 100,000.00 1/23/2018 1032 Roger Forsyth 100,000.00 2/9/2018 1033 Lawrence Wesigal 15,000.00 3/19/2018 1034 Donald Steinberg 150,000.00 3/15/2018 1035 Donald Harrington 12,500.00 4/26/2018 1036 Roger Seabre 100,000.00 4/26/2018 1037 Michael Kirk Wines 100,000.00 5/7/2018 1038 Donald Steinberg 400,000.00 5/15/2018 1039 Roger Seabre 200,000.00 6/13/2018 1040 Blue Ridge Enterprises 450,000.00 6/26/2018 1041 Dianna Steinberg 200,000.00 Total 1,927,500.00 A summary of the Company’s outstanding common stock warrants is as follows as of December 31, 2019: Issuance Warrant # of Common Strike Date # Name Document Stock Warrants Price 12/31/2017 1,973,333 1/2/2018 1009 Exercise - Edward Matkoff Subscription Agreement -50,000 $ 3.00 1/5/2018 1029 Lex Seabre Subscription Agreement 100,000 $ 5.00 1/21/2018 1031 Roger Forsyth Subscription Agreement 100,000 $ 12.50 1/23/2018 1010 Expired - Sandra Hogan Subscription Agreement -2,000 $ 3.00 1/23/2018 1032 Roger Forsyth Subscription Agreement 100,000 $ 12.50 2/9/2018 1033 Lawrence Wesigal Subscription Agreement 15,000 $ 12.50 3/19/2018 1034 Donald Steinberg Subscription Agreement 150,000 $ 5.00 3/15/2018 1035 Donald Harrington Subscription Agreement 12,500 $ 5.00 4/20/2017 1015 Expired - Lex Seabre Subscription Agreement -375,000 $ 3.00 4/20/2017 1020 Expired - Lex Seabre Subscription Agreement -125,000 $ 3.00 4/26/2018 1036 Roger Seabre Subscription Agreement 100,000 $ 5.00 4/26/2018 1037 Michael Kirk Wines Subscription Agreement 100,000 $ 5.00 5/7/2018 1038 Donald Steinberg Subscription Agreement 400,000 $ 6.00 5/15/2018 1039 Roger Seabre Subscription Agreement 200,000 $ 6.00 6/13/2018 1040 Blue Ridge Enterprises Subscription Agreement 450,000 $ 6.00 6/16/2017 1019 Expired - Black Mountain Equities Debt Exchange Agreement -70,000 $ 3.00 6/26/2018 1041 Dianna Steinberg Subscription Agreement 200,000 $ 6.00 12/31/2018 3,278,833 1/5/2018 1029 Expired - Lex Seabre Subscription Agreement -100,000 $ 5.00 2/9/2018 1033 Expired - Lawrence Wesigal Subscription Agreement -15,000 $ 12.50 3/19/2018 1034 Expired - Donald Steinberg Subscription Agreement -150,000 $ 5.00 3/15/2018 1035 Expired - Donald Harrington Subscription Agreement -12,500 $ 5.00 4/26/2018 1036 Expired -Roger Seabre Subscription Agreement -100,000 $ 5.00 4/26/2018 1037 Expired -Michael Kirk Wines Subscription Agreement -100,000 $ 5.00 5/7/2018 1038 Expired -Donald Steinberg Subscription Agreement -400,000 $ 6.00 5/15/2018 1039 Expired -Roger Seabre Subscription Agreement -200,000 $ 6.00 6/13/2018 1040 Expired -Blue Ridge Enterprises Subscription Agreement -450,000 $ 6.00 6/26/2018 1041 Expired -Dianna Steinberg Subscription Agreement -200,000 $ 6.00 5/25/2017 1016 Expired -Russ Karlen Subscription Agreement -100,000 $ 3.00 5/25/2017 1017 Expired -Eric Karlen Subscription Agreement -20,000 $ 3.00 5/31/2017 1018 Expired -Matt Turner Subscription Agreement -20,000 $ 3.00 5/31/2017 1022 Expired -Rodger Seabre Subscription Agreement -300,000 $ 3.00 7/7/2017 1021 Expired - Rodger Seabre Subscription Agreement -200,000 $ 3.00 8/2/2017 1026 Expired - Rodger Seabre Subscription Agreement -100,000 $ 3.00 9/5/2017 1023 Expired - Harry Methewson #1 Subscription Agreement -40,000 $ 3.00 9/24/2017 1024 Expired - Harry Methewson #2 Subscription Agreement -133,000 $ 3.00 9/29/2017 1025 Expired - A2Z Inc. Subscription Agreement -300,000 $ 3.00 10/24/2017 1027 Expired - Salvatore Rutigliano Subscription Agreement -13,3333 $ 3.00 11/10/2017 1028 Expired - Roger Seabre Subscription Agreement -125,000 $ 3.00 12/31/2019 200,000 Common Stock Warrants Expired (2019) A total of 3,078,833 warrants expired during the year ended December 31, 2019. Warrants Exercised (2019) No warrants were exercised during the year ended December 31, 2019. 2018 Common Stock Warrant Activity Common Stock Warrants Granted (2018) See Note 10 for details on warrants issued during the year ended December 31, 2018. Common Stock Warrants Exercised (2018) On January 12, 2018, a warrant holder exercised warrants to purchase 150,000 shares of common stock at a price of $1.50 in exchange for proceeds of $225,000. Common Stock Warrants Expired (2018) A total of 572,000 warrants expired during the year ended December 31, 2018. Common Stock Options (2018) On February 1, 2018, in connection with executive employment agreements, the Company granted non-qualified options to purchase an aggregate of 6,000,000 shares of the Company’s common stock at the exercise price of $10.55 per share. The options shall become exercisable at the rate of 1/3 upon the six-month anniversary, 1/3 upon the one-year anniversary and 1/3 upon the second anniversary of the grant. The options expire ten years from the date of grant. The options were valued at $45,753,000 using the Black-Scholes option pricing model. The Company recognized expense of approximately $22,770,662 and $21,201,397 relating to these options during the year ended December 31, 2019 and December 31, 2018, respectively. The assumptions used in the Black-Scholes model are as follows: For the period Risk-free interest rate 1.75% Expected dividend yield 0% Expected lives 10.0 years Expected volatility 200% A summary of the Company’s stock option activity and related information is as follows: For the Year Ended Number of Average Shares Price Outstanding at the beginning of period $ - $ - Granted 6,000,000 10.55 Exercised/Expired/Cancelled - - Outstanding at the end of period 6,000,000 $ 10.55 Exercisable at the end of period 1,250,000 $ 10.55

Income Tax

Income Tax	12 Months Ended
	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Income Tax	The Company accounts for income taxes under FASB ASC 740-10, which requires use of the liability method. FASB ASC 740-10-25 provides that deferred tax assets and liabilities are recorded based on the differences between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes, referred to as temporary differences. For the years ended December 31, 2019 and 2018, the Company incurred a net operating loss and, accordingly, no provision for income taxes has been recorded. In addition, no benefit for income taxes has been recorded due to the uncertainty of the realization of any tax assets. At December 31, 2019 and December 31, 2018, the Company had approximately $10,786,000 and $8,179,000 of federal net operating losses, respectively. The net operating loss carry forwards, if not utilized, will begin to expire in 2031. The components of the Company’s deferred tax asset are as follows: December 31, 2019 December 31, 2018 Deferred tax assets: Net operating loss carry forwards 59,276,171 31,276,171 Net deferred tax assets before valuation allowance 59,276,171 31,276,171 Less: Valuation allowance (59,276,171 ) (31,276,171 ) Net deferred tax assets - - The 2017 Act reduces the corporate tax rate from 34% to 21% for tax years beginning after December 31, 2017. Based on the available objective evidence, including the Company’s history of losses, management believes it is more likely than not that the net deferred tax assets will not be fully realizable. Accordingly, the Company provided for a full valuation allowance against its net deferred tax assets at December 31, 2019 and 2018, respectively.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2019
Subsequent Events [Abstract]
Subsequent events	Common Stock Sales On January 29, 2020, the Company sold 50,000 shares of common stock in exchange for total proceeds of $15,000. On February 18, 2020, the Company sold 100,000 shares of common stock in exchange for total proceeds of $25,000. On February 18, 2020, the Company sold 100,000 shares of common stock in exchange for total proceeds of $15,000. Common Stock Issued for Services On January 29, 2020, the Company issued 200,000 shares to the Robert Wolkin in exchange for services rendered to the Company. On January 29, 2020, the Company issued 600,000 shares to the Craig Butler in exchange for services rendered to the Company. On January 29, 2020, the Company issued 100,000 shares to the Soul Singh in exchange for services rendered to the Company. On January 29, 2020, the Company issued 30,000 shares to the Beverly Weiss in exchange for services rendered to the Company. On February 18, 2020, the Company issued 100,000 shares to the Sal Rutigliano in exchange for services rendered to the Company. On February 18, 2020, the Company issued 100,000 shares to the Eilers Law Group in exchange for services rendered to the Company. On February 18, 2020, the Company issued 24,000 shares to the Advance CFO Solutions in exchange for services rendered to the Company. On February 18, 2020, the Company issued 44,800 shares to the Insight Performance Consulting in exchange for services rendered to the Company. On February 18, 2020, the Company issued 11,200 shares to the JB Henriksen in exchange for services rendered to the Company. The Company entered into Memorandum of Sale agreement for the Sugar Hill property with M&T Bank and the Referee to make payment of $10,000 per month commencing on February 1, 2020 and continuing on the 1 st

Nature of Business and Signif_2

Nature of Business and Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
Nature of Business	WEED, Inc. (the “Company”), (formerly United Mines, Inc.) was incorporated under the laws of the State of Arizona on August 20, 1999 (“Inception Date”) as Plae, Inc. to engage in the exploration of gold and silver mining properties. On November 26, 2014, the Company was renamed from United Mines, Inc. to WEED, Inc. and was repurposed to pursue a business involving the purchase of land, and building Commercial Grade “Cultivation Centers” to consult, assist, manage & lease to Licensed Dispensary owners and organic grow operators on a contract basis, with a concentration on the legal and medical marijuana sector. The Company’s plan is to become a True “Seed-to-Sale” company providing infrastructure, financial solutions and real estate options in this new emerging market. The Company, under United Mines, was formerly in the process of acquiring mineral properties or claims located in the State of Arizona, USA. The name was previously changed on February 18, 2005 to King Mines, Inc. and then subsequently changed to United Mines, Inc. on March 30, 2005. The Company trades on the OTC Pink Sheets under the stock symbol: BUDZ. On April 20, 2017, the Company acquired Sangre AT, LLC, a Wyoming company doing business as Sangre AgroTech. (“Sangre”). Sangre is a plant genomic research and breeding company comprised of top-echelon scientists with extensive expertise in genomic sequencing, genetics-based breeding, plant tissue culture, and plant biochemistry, utilizing the most advanced sequencing and analytical technologies and proprietary bioinformatics data systems available. No work is being conducted now until further funds are available. The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America. These statements reflect all adjustments, consisting of normal recurring adjustments, which in the opinion of management are necessary for fair presentation of the information contained therein. The Company has a calendar year end for reporting purposes.
Basis of Presentation	The accompanying condensed consolidated balance sheet at December 31, 2019, has been derived from audited consolidated financial statements and the unaudited condensed consolidated financial statements as of June 30, 2019 and 2018 ( the “financial statements”), have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements and should be read in conjunction with the audited consolidated financial statements and related footnotes included in our Registration Statement on Form S-1 for the year ended December 31, 2019 (the “2019 Annual Report”), filed with the Securities and Exchange Commission (the “SEC”). It is management’s opinion, however, that all material adjustments (consisting of normal recurring adjustments), have been made which are necessary for a fair financial statements presentation. The condensed consolidated financial statements include all material adjustments (consisting of normal recurring accruals) necessary to make the condensed consolidated financial statements not misleading as required by Regulation S-X, Rule 10-01.
Principles of Consolidation	The accompanying consolidated financial statements include the accounts of the following entities, all of which are under common control and ownership: State of Abbreviated Name of Entity Incorporation Relationship (1) Reference WEED, Inc. Nevada Parent WEED Sangre AT, LLC (2) Wyoming Subsidiary Sangre (1) Sangre is a wholly-owned subsidiary of WEED, Inc. (2) Sangre AT, LLC is doing business as Sangre AgroTech. The consolidated financial statements herein contain the operations of the wholly-owned subsidiary listed above. All significant inter-company transactions have been eliminated in the preparation of these financial statements. The parent company, WEED and subsidiary, Sangre will be collectively referred to herein as the “Company”, or “WEED”. The Company’s headquarters are located in Tucson, Arizona and its operations are primarily within the United States, with minimal operations in Australia. These statements reflect all adjustments, consisting of normal recurring adjustments, which in the opinion of management are necessary for fair presentation of the information contained therein.
Use of Estimates	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Fair Value of Financial Instruments	Under FASB ASC 820-10-05, the Financial Accounting Standards Board establishes a framework for measuring fair value in generally accepted accounting principles and expands disclosures about fair value measurements. This Statement reaffirms that fair value is the relevant measurement attribute. The adoption of this standard did not have a material effect on the Company’s financial statements as reflected herein. The carrying amounts of cash, prepaid expenses and accrued expenses reported on the balance sheet are estimated by management to approximate fair value primarily due to the short term nature of the instruments.
Impairment of Long-Lived Assets	Long-lived assets held and used by the Company are reviewed for possible impairment whenever events or circumstances indicate the carrying amount of an asset may not be recoverable or is impaired. Recoverability is assessed using undiscounted cash flows based upon historical results and current projections of earnings before interest and taxes. Impairment is measured using discounted cash flows of future operating results based upon a rate that corresponds to the cost of capital. Impairments are recognized in operating results to the extent that carrying value exceeds discounted cash flows of future operations.
Basic and Diluted Loss Per Share	The basic net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding. Diluted net loss per common share is computed by dividing the net loss adjusted on an “as if converted” basis, by the weighted average number of common shares outstanding plus potential dilutive securities. For the periods presented, potential dilutive securities had an anti-dilutive effect and were not included in the calculation of diluted net loss per common share.
Stock-Based Compensation	Under FASB ASC 718-10-30-2, all share-based payments to employees, including grants of employee stock options, to be recognized in the income statement based on their fair values. Pro forma disclosure is no longer an alternative.
Revenue Recognition	On January 1, 2018, the Company adopted the new revenue recognition standard ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)”, using the cumulative effect (modified retrospective) approach. Modified retrospective adoption requires entities to apply the standard retrospectively to the most current period presented in the financial statements, requiring the cumulative effect of the retrospective application as an adjustment to the opening balance of retained earnings at the date of initial application. No cumulative-effect adjustment in retained earnings was recorded as the Company’s has no historical revenue. The impact of the adoption of the new standard was not material to the Company’s condensed consolidated financial statements for the year ended December 31, 2019. The Company expects the impact to be immaterial on an ongoing basis. The primary change under the new guidance is the requirement to report the allowance for uncollectible accounts as a reduction in net revenue as opposed to bad debt expense, a component of operating expenses. The adoption of this guidance did not have an impact on our condensed consolidated financial statements, other than additional financial statement disclosures. The guidance requires increased disclosures, including qualitative and quantitative disclosures about the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The Company operates as one reportable segment. Sales on fixed price contracts are recorded when services are earned, the earnings process is complete or substantially complete, and the revenue is measurable and collectability is reasonably assured. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. The Company will defer any revenue from sales in which payment has been received, but the earnings process has not occurred. Sales have not yet commenced.
Advertising and Promotion	All costs associated with advertising and promoting products are expensed as incurred. These expenses were $3,450 and $998 for the years ended December 31, 2019 and 2018.
Recently Issued Accounting Pronouncements	In August 2018, the FASB issued ASU 2018-15 Accounting for Implementation Costs Related to Cloud Computing or Hosting Arrangements. This standard provides authoritative guidance intended to address a customer’s accounting for implementation costs incurred in a cloud computing arrangement that is a service contract. This guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The guidance also requires presentation of the capitalized implementation costs in the statement of financial position and in the statement of cash flows in the same line item that a prepayment for the fees of the associated hosting arrangement would be presented, and the expense related to the capitalized implementation costs to be presented in the same line item in the statement of operations as the fees associated with the hosting element (service) of the arrangement. This guidance is effective for annual periods beginning after December 15, 2019, including interim periods within those annual periods, with early adoption permitted. We are currently evaluating the potential impact on our financial position, results of operations and statement of cash flows upon adoption of this guidance. We do not expect this guidance to have a significant impact, or potential significant impact, to our unaudited condensed consolidated interim financial statements. In February 2016, the FASB issued ASU 2016-02, Leases. The standard requires lessees to recognize lease assets and lease liabilities on the consolidated balance sheet and requires expanded disclosures about leasing arrangements. We plan to adopt the standard on January 1, 2019. We are currently assessing the impact that the new standard will have on our consolidated financial statements, which will consist primarily of a balance sheet gross up of our operating leases to show equal and offsetting lease assets and lease liabilities. The Company adopted the new lease guidance effective January 1, 2019 using the modified retrospective transition approach, applying the new standard to all of its leases existing at the date of initial application which is the effective date of adoption. Consequently, financial information will not be updated and the disclosures required under the new standard will not be provided for dates and periods before January 1, 2019. We elected the package of practical expedients which permits us to not reassess (1) whether any expired or existing contracts are or contain leases, (2) the lease classification for any expired or existing leases, and (3) any initial direct costs for any existing leases as of the effective date. We did not elect the hindsight practical expedient which permits entities to use hindsight in determining the lease term and assessing impairment. The adoption of the lease standard did not change our previously reported consolidated statements of operations and did not result in a cumulative catch-up adjustment to opening equity. As of December 31, 2019, the adoption of the standard had no impact on the Company, as there were no leases in place longer than 12 months. In June 2018, the FASB issued Accounting Standards Update (“ASU”) 2018-07, Compensation – Stock Compensation (Topic 718) Improvements to Nonemployee Share-Based Payment Accounting

Nature of Business and Signif_3

Nature of Business and Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
Schedule of entities	State of Abbreviated Name of Entity Incorporation Relationship (1) Reference WEED, Inc. Nevada Parent WEED Sangre AT, LLC (2) Wyoming Subsidiary Sangre

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2019
Financial Instruments, Owned, at Fair Value [Abstract]
Fair value of financial instruments	Level 1 Level 2 Level 3 Assets Cash $ 70,608 $ - $ - Total assets $ 70,608 $ - $ - Liabilities Notes payable, related parties Notes payable $ - $ 12,000 $ - Total liabilities $ - $ 12,000 $ - $ 70,608 $ 12,000 $ - Fair Value Measurements at December 31, 2019 Level 1 Level 2 Level 3 Assets Cash $ 2,509 $ - $ - Total assets $ 2,509 $ - $ - Liabilities Notes payable, related parties $ 224,100 Notes payable $ - $ 167,263 $ - Total liabilities $ - $ 391,363 $ - $ 2,509 $ 391,363 $ -

Investment in Land and Proper_2

Investment in Land and Property (Tables)	12 Months Ended
	Dec. 31, 2019
Investments [Abstract]
Investment in land and property	July 26, 2017 Consideration: Common stock payment of 25,000 shares (1) $ 30,000 Cash payment of down payment 50,000 Cash paid at closing 44,640 Short term liabilities assumed and paid at closing (2) 5,360 Note payable (3) 475,000 Total purchase price $ 1,005,000

Property and Equipment (Tables)

Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2019
Property, Plant and Equipment [Abstract]
Property and equipment	December 31, December 31, 2019 2018 Property improvements $ 5,000 $ 5,000 Automobiles 0 105,132 Office equipment 4,933 4,933 Furniture & Fixtures 2,979 0 Lab equipment 65,769 65,769 Construction in progress 0 499,695 Property (1) 1,887,802 1,887,802 Property and equipment, gross 1,966,483 2,568,331 Less accumulated depreciation (322,498 ) (224,198 ) Property and equipment, net $ 1,643,985 2,344,133

Notes Payable, Related Parties

Notes Payable, Related Parties (Tables)	12 Months Ended
	Dec. 31, 2019
Notes Payable [Abstract]
Notes payable, related parties	December 31, 2019 December 31, 2018 On April 12, 2010, the Company received an unsecured, non-interest-bearing loan in the amount of $2,000, due on demand from Robert Leitzman. Interest is being imputed at the Company’s estimated borrowing rate, or 10% per annum. The largest aggregate amount outstanding was $2,000 during the periods ended December 31, 2019 and December 31, 2018. Mr. Leitzman owns less than 1% of the Company’s common stock, however, the Mr. Leitzman is deemed to be a related party given the non-interest-bearing nature of the loan and the materiality of the debt at the time of origination. 2,000 2,000 Over various dates in 2011 and 2012, the Company received unsecured loans in the aggregate amount of $10,000, due on demand, bearing interest at 10%, from Sandra Orman. The largest aggregate amount outstanding was $10,000 during the periods ended December 31, 2019 and December 31, 2018. Mrs. Orman owns less than 1% of the Company’s common stock, however, Mrs. Orman is deemed to be a related party given the nature of the loan and the materiality of the debt at the time of origination. 10,000 10,000 Over various dates from April to December 2019, the company received a total of $305,100 of advances, bearing interest at 5%, from Nicole Breen. A detailed list of advances and repayments follows. On October 28, 2019, the company’s vehicles valued at $93,000 were used as a repayment. 212,100 0 Notes payable, related parties $ 224,100 $ 12,000

Notes Payable (Tables)

Notes Payable (Tables)	12 Months Ended
	Dec. 31, 2019
Notes Payable [Abstract]
Note payable	December 31, 2019 December 31, 2018 On July 26, 2017, the Company issued a $475,000 note payable, bearing interest at 5% per annum, to A.R. Miller (“Miller Note”) pursuant to the purchase of land and property in La Veta, Colorado. The note is to be paid in four consecutive semi-annual installments in the amount of $118,750 plus accrued interest commencing on January 26, 2018 and continuing on the 26th day of July and the 26th day of January each year until the debt is repaid on July 26, 2019. The note carries a late fee of $5,937.50 in the event any installment payment is more than 30 days late, and upon default the interest rate shall increase to 12% per annum. During the three months ended March 31, 2018, the Company issued 125,000 shares of common stock, valued at $1,450,000 based on the closing price on the measurement date. Accordingly, the Company recorded a loss on extinguishment of $1,064,719. $ - $ - On February 16, 2018, the Company issued a $1,040,662 note payable, bearing interest at 1.81% per annum (the low interest rate was due to the short-term nature of the note – six months. See Note 6), to Craig and Carol Clark (“Clark Note”) pursuant to the purchase of land and property in La Veta, Colorado. The note is to be paid in consecutive monthly installments in the amount of $5,000, including accrued interest commencing on March 15, 2018 and continuing through August 15, 2018. The note carries a late fee of 3% in the event any installment payment is more than 10 days late, and upon default the interest rate shall increase to 10% per annum. As of September 12, 2018, a total of $171,300 was paid to the note holder. On October 9, 2018, the Company entered into a settlement agreement with the note holder to pay the settlement payment of $750,000. The Company had already paid $650,000 by September 27, 2018 and made the remaining payment of $100,000 on October 10, 2018. The Company recorded a gain on extinguishment of $121,475. On August 5, 2019, the Company entered into a promissory note, whereby the Company promises to pay Snell & Wilmer L.L.P the principal amount of $250,000, bearing interest at 2.5% per annum. The note is to be paid in consecutive monthly installments in the amount of $25,000, including accrued interest commencing on August 30, 2019, until the final balloon payment is paid on January 30, 2020. The promissory note is secured by the Deed of Trust, Assignment of Leases and Rents, Security Agreement and Fixture Filing with respect to the real property owned by Sangre located on 1390 Mountain Valley Road, La Veta, Colorado 81055. As of December 31, 2019, $83,588 has been paid to Snell & Wilmer. $ 166,412 On various dates, the Company received advances from consultant, Patrick Brodnik, bearing 0% interest. $ 850 $ 167,262 $ -

Common Stock Warrants and Opt_2

Common Stock Warrants and Options (Tables)	12 Months Ended
	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Warrants granted	2019 2018 Issuance Warrant # of Common Issuance Warrant # of Common Date # Name Stock Warrants Date # Name Stock Warrants 1/5/2018 1029 Lex Seabre 100,000.00 Total - 1/21/2018 1031 Roger Forsyth 100,000.00 1/23/2018 1032 Roger Forsyth 100,000.00 2/9/2018 1033 Lawrence Wesigal 15,000.00 3/19/2018 1034 Donald Steinberg 150,000.00 3/15/2018 1035 Donald Harrington 12,500.00 4/26/2018 1036 Roger Seabre 100,000.00 4/26/2018 1037 Michael Kirk Wines 100,000.00 5/7/2018 1038 Donald Steinberg 400,000.00 5/15/2018 1039 Roger Seabre 200,000.00 6/13/2018 1040 Blue Ridge Enterprises 450,000.00 6/26/2018 1041 Dianna Steinberg 200,000.00 Total 1,927,500.00
Warrants outstanding	Issuance Warrant # of Common Strike Date # Name Document Stock Warrants Price 12/31/2017 1,973,333 1/2/2018 1009 Exercise - Edward Matkoff Subscription Agreement -50,000 $ 3.00 1/5/2018 1029 Lex Seabre Subscription Agreement 100,000 $ 5.00 1/21/2018 1031 Roger Forsyth Subscription Agreement 100,000 $ 12.50 1/23/2018 1010 Expired - Sandra Hogan Subscription Agreement -2,000 $ 3.00 1/23/2018 1032 Roger Forsyth Subscription Agreement 100,000 $ 12.50 2/9/2018 1033 Lawrence Wesigal Subscription Agreement 15,000 $ 12.50 3/19/2018 1034 Donald Steinberg Subscription Agreement 150,000 $ 5.00 3/15/2018 1035 Donald Harrington Subscription Agreement 12,500 $ 5.00 4/20/2017 1015 Expired - Lex Seabre Subscription Agreement -375,000 $ 3.00 4/20/2017 1020 Expired - Lex Seabre Subscription Agreement -125,000 $ 3.00 4/26/2018 1036 Roger Seabre Subscription Agreement 100,000 $ 5.00 4/26/2018 1037 Michael Kirk Wines Subscription Agreement 100,000 $ 5.00 5/7/2018 1038 Donald Steinberg Subscription Agreement 400,000 $ 6.00 5/15/2018 1039 Roger Seabre Subscription Agreement 200,000 $ 6.00 6/13/2018 1040 Blue Ridge Enterprises Subscription Agreement 450,000 $ 6.00 6/16/2017 1019 Expired - Black Mountain Equities Debt Exchange Agreement -70,000 $ 3.00 6/26/2018 1041 Dianna Steinberg Subscription Agreement 200,000 $ 6.00 12/31/2018 3,278,833 1/5/2018 1029 Expired - Lex Seabre Subscription Agreement -100,000 $ 5.00 2/9/2018 1033 Expired - Lawrence Wesigal Subscription Agreement -15,000 $ 12.50 3/19/2018 1034 Expired - Donald Steinberg Subscription Agreement -150,000 $ 5.00 3/15/2018 1035 Expired - Donald Harrington Subscription Agreement -12,500 $ 5.00 4/26/2018 1036 Expired -Roger Seabre Subscription Agreement -100,000 $ 5.00 4/26/2018 1037 Expired -Michael Kirk Wines Subscription Agreement -100,000 $ 5.00 5/7/2018 1038 Expired -Donald Steinberg Subscription Agreement -400,000 $ 6.00 5/15/2018 1039 Expired -Roger Seabre Subscription Agreement -200,000 $ 6.00 6/13/2018 1040 Expired -Blue Ridge Enterprises Subscription Agreement -450,000 $ 6.00 6/26/2018 1041 Expired -Dianna Steinberg Subscription Agreement -200,000 $ 6.00 5/25/2017 1016 Expired -Russ Karlen Subscription Agreement -100,000 $ 3.00 5/25/2017 1017 Expired -Eric Karlen Subscription Agreement -20,000 $ 3.00 5/31/2017 1018 Expired -Matt Turner Subscription Agreement -20,000 $ 3.00 5/31/2017 1022 Expired -Rodger Seabre Subscription Agreement -300,000 $ 3.00 7/7/2017 1021 Expired - Rodger Seabre Subscription Agreement -200,000 $ 3.00 8/2/2017 1026 Expired - Rodger Seabre Subscription Agreement -100,000 $ 3.00 9/5/2017 1023 Expired - Harry Methewson #1 Subscription Agreement -40,000 $ 3.00 9/24/2017 1024 Expired - Harry Methewson #2 Subscription Agreement -133,000 $ 3.00 9/29/2017 1025 Expired - A2Z Inc. Subscription Agreement -300,000 $ 3.00 10/24/2017 1027 Expired - Salvatore Rutigliano Subscription Agreement -13,3333 $ 3.00 11/10/2017 1028 Expired - Roger Seabre Subscription Agreement -125,000 $ 3.00 12/31/2019 200,000
Fair value of options assumptions	For the period Risk-free interest rate 1.75% Expected dividend yield 0% Expected lives 10.0 years Expected volatility 200%
Stock option activity	For the Year Ended Number of Average Shares Price Outstanding at the beginning of period $ - $ - Granted 6,000,000 10.55 Exercised/Expired/Cancelled - - Outstanding at the end of period 6,000,000 $ 10.55 Exercisable at the end of period 1,250,000 $ 10.55

Income Tax (Tables)

Income Tax (Tables)	12 Months Ended
	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Deferred tax assets	December 31, 2019 December 31, 2018 Deferred tax assets: Net operating loss carry forwards 59,276,171 31,276,171 Net deferred tax assets before valuation allowance 59,276,171 31,276,171 Less: Valuation allowance (59,276,171 ) (31,276,171 ) Net deferred tax assets - -

Nature of Business and Signif_4

Nature of Business and Significant Accounting Policies (Details)	12 Months Ended
	Dec. 31, 2019
Parent
Name of Entity	WEED, Inc.
State of Incorporation	Nevada
Subsidiary
Name of Entity	Sangre AT, LLC	[1],[2]
State of Incorporation	Wyoming
[1]	Sangre AT, LLC is doing business as Sangre AgroTech.
[2]	Sangre is a wholly-owned subsidiary of WEED, Inc.

Nature of Business and Signif_5

Nature of Business and Significant Accounting Policies (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Accounting Policies [Abstract]
Advertising and promotion expense	$ 3,450	$ 998

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Going Concern
Accumulated deficit	$ (75,925,974)	$ (48,396,295)

Related Party (Details Narrativ

Related Party (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Related Party Transactions [Abstract]
Imputed interest on non-interest bearing related party debts	$ 0	$ 0
Officer compensation	122,250	122,250
Estimated fair value of vested stock options	$ 22,770,662	$ 21,284,610

Fair Value of Financial Instr_3

Fair Value of Financial Instruments (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Assets
Cash	$ 2,509	$ 70,608	$ 161,178
Total assets	1,952,612	3,020,989
Liabilities
Notes payable, related parties	224,100	12,000
Notes payable	167,263	0
Total liabilities	752,970	259,362
Level 1
Assets
Cash	2,509	70,608
Total assets	2,509	70,608
Liabilities
Notes payable, related parties	0	0
Notes payable	0
Total liabilities	0	0
Total	2,509	70,608
Level 2
Assets
Cash	0	0
Total assets	0	0
Liabilities
Notes payable, related parties	224,100	12,000
Notes payable	167,263
Total liabilities	391,363	12,000
Total	391,363	12,000
Level 3
Assets
Cash	0	0
Total assets	0	0
Liabilities
Notes payable, related parties	0	0
Notes payable	0
Total liabilities	0	0
Total	$ 0	$ 0

Investment in Land and Proper_3

Investment in Land and Property (Details)	12 Months Ended
	Dec. 31, 2018USD ($)
Total purchase price	$ 1,005,000
Common stock payment
Total purchase price	30,000
Cash payment of down payment
Total purchase price	50,000
Cash paid at closing
Total purchase price	44,640
Short term liabilities assumed and paid at closing
Total purchase price	5,360
Note payable
Total purchase price	$ 475,000

Property and Equipment (Details

Property and Equipment (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Property and equipment, gross	$ 1,966,483	$ 2,568,331
Less accumulated depreciation	(322,498)	(224,198)
Property and equipment, net	1,643,985	2,344,133
Property improvements
Property and equipment, gross	5,000	5,000
Automobiles
Property and equipment, gross	0	105,132
Office equipment
Property and equipment, gross	4,933	4,933
Furniture and Fixtures
Property and equipment, gross	2,979	0
Lab equipment
Property and equipment, gross	65,765	65,769
Construction in progress
Property and equipment, gross	0	499,695
Property
Property and equipment, gross	$ 1,887,802	$ 1,887,802

Property and Equipment (Detai_2

Property and Equipment (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Property, Plant and Equipment [Abstract]
Depreciation and amortization expense	$ 159,423	$ 180,640

Intangible Assets (Details Narr

Intangible Assets (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Intangible Assets, Net (Including Goodwill) [Abstract]
Amortization of intangible assets	$ 2,600	$ 1,484

Notes Payable, Related Partie_2

Notes Payable, Related Parties (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Notes payable, related parties	$ 224,100	$ 12,000
Note payable 1
Notes payable, related parties	2,000	0
Note payable 2
Notes payable, related parties	10,000	0
Note payable 3
Notes payable, related parties	212,100	2,000
Note payable 4
Notes payable, related parties	$ 0	$ 10,000

Notes Payable, Related Partie_3

Notes Payable, Related Parties (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Notes Payable [Abstract]
Interest expense	$ 9,264	$ 12,179
Imputed interest on non-interest bearing related party debts	$ 0	$ 0

Notes Payable (Details)

Notes Payable (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Advances from consultant	$ 850
Notes payable	167,263	$ 0
Note payable 1
Notes payable		0
Note payable 2
Notes payable		0
Note payable 3
Notes payable	$ 166,412	$ 0

Notes Payable (Details Narrativ

Notes Payable (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Notes Payable [Abstract]
Interest expense	$ 2,408	$ 0

Common Stock Warrants and Opt_3

Common Stock Warrants and Options (Details) - shares	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Common stock warrants granted	1,927,500	1,927,500
Warrant 1
Issuance date	Jan. 5, 2018	Jan. 5, 2018
Common stock warrants granted	100,000	100,000
Warrant 2
Issuance date	Jan. 21, 2018	Jan. 21, 2018
Common stock warrants granted	100,000	100,000
Warrant 3
Issuance date	Jan. 23, 2018	Jan. 23, 2018
Common stock warrants granted	100,000	100,000
Warrant 4
Issuance date	Feb. 9, 2018	Feb. 9, 2018
Common stock warrants granted	15,000	15,000
Warrant 5
Issuance date	Mar. 19, 2018	Mar. 19, 2018
Common stock warrants granted	150,000	150,000
Warrant 6
Issuance date	Mar. 15, 2018	Mar. 15, 2018
Common stock warrants granted	12,500	12,500
Warrant 7
Issuance date	Apr. 26, 2018	Apr. 26, 2018
Common stock warrants granted	100,000	100,000
Warrant 8
Issuance date	Apr. 26, 2018	Apr. 26, 2018
Common stock warrants granted	100,000	100,000
Warrant 9
Issuance date	May 7, 2018	May 7, 2018
Common stock warrants granted	400,000	400,000
Warrant 10
Issuance date	May 15, 2018	May 15, 2018
Common stock warrants granted	200,000	200,000
Warrant 11
Issuance date	Jun. 13, 2018	Jun. 13, 2018
Common stock warrants granted	450,000	450,000
Warrant 12
Issuance date	Jun. 26, 2018	Jun. 26, 2018
Common stock warrants granted	200,000	200,000

Common Stock Warrants and Opt_4

Common Stock Warrants and Options (Details 1) - $ / shares	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Common stock warrants oustanding	200,000	3,278,833
Warrant 1
Issuance date	Jan. 5, 2018	Jan. 2, 2018
Common stock warrants oustanding	(100,000)	(50,000)
Strike price	$ 5	$ 3
Warrant 2
Issuance date	Feb. 9, 2018	Jan. 5, 2018
Common stock warrants oustanding	(15,000)	100,000
Strike price	$ 12.5	$ 5
Warrant 3
Issuance date	Mar. 19, 2018	Jan. 21, 2018
Common stock warrants oustanding	(150,000)	100,000
Strike price	$ 5	$ 12.50
Warrant 4
Issuance date	Mar. 15, 2018	Jan. 23, 2018
Common stock warrants oustanding	(12,500)	(2,000)
Strike price	$ 5	$ 3
Warrant 5
Issuance date	Apr. 26, 2018	Jan. 23, 2018
Common stock warrants oustanding	(100,000)	100,000
Strike price	$ 5	$ 12.50
Warrant 6
Issuance date	Apr. 26, 2018	Feb. 9, 2018
Common stock warrants oustanding	(100,000)	15,000
Strike price	$ 5	$ 12.50
Warrant 7
Issuance date	May 7, 2018	Mar. 19, 2018
Common stock warrants oustanding	(400,000)	150,000
Strike price	$ 6	$ 5
Warrant 8
Issuance date	May 15, 2018	Mar. 15, 2018
Common stock warrants oustanding	(200,000)	12,500
Strike price	$ 6	$ 5
Warrant 9
Issuance date	Jun. 13, 2018	Apr. 20, 2018
Common stock warrants oustanding	(450,000)	(375,000)
Strike price	$ 6	$ 3
Warrant 10
Issuance date	Jun. 26, 2018	Apr. 20, 2018
Common stock warrants oustanding	(200,000)	(125,000)
Strike price	$ 6	$ 3
Warrant 11
Issuance date	May 25, 2017	Apr. 26, 2018
Common stock warrants oustanding	(100,000)	100,000
Strike price	$ 3	$ 5
Warrant 12
Issuance date	May 25, 2017	Apr. 26, 2018
Common stock warrants oustanding	(20,000)	100,000
Strike price	$ 3	$ 5
Warrant 13
Issuance date	May 31, 2017	May 7, 2018
Common stock warrants oustanding	(20,000)	400,000
Strike price	$ 3	$ 6
Warrant 15
Issuance date	May 31, 2017	May 15, 2018
Common stock warrants oustanding	(300,000)	200,000
Strike price	$ 3	$ 6
Warrant 15
Issuance date	Jul. 7, 2017	Jun. 13, 2018
Common stock warrants oustanding	(200,000)	450,000
Strike price	$ 3	$ 6
Warrant 16
Issuance date	Aug. 2, 2017	Jun. 16, 2018
Common stock warrants oustanding	(100,000)	(70,000)
Strike price	$ 3	$ 3
Warrant 17
Issuance date	Sep. 5, 2017	Jun. 26, 2018
Common stock warrants oustanding	(40,000)	200,000
Strike price	$ 3	$ 6
Warrant 18
Issuance date	Sep. 24, 2017
Common stock warrants oustanding	(133,000)
Strike price	$ 3
Warrant 19
Issuance date	Sep. 29, 2017
Common stock warrants oustanding	(300,000)
Strike price	$ 3
Warrant 20
Issuance date	Oct. 24, 2017
Common stock warrants oustanding	(133,333)
Strike price	$ 3
Warrant 21
Issuance date	Nov. 10, 2017
Common stock warrants oustanding	(125,000)
Strike price	$ 3

Common Stock Warrants and Opt_5

Common Stock Warrants and Options (Details 2)	12 Months Ended
	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Risk-free interest rate	1.75%
Expected dividend yield	0.00%
Expected lives	10 years
Expected volatility	200.00%

Common Stock Warrants and Opt_6

Common Stock Warrants and Options (Details 3)	12 Months Ended
	Dec. 31, 2019$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Number of options outstanding, beginning | shares	0
Number of options granted | shares	6,000,000
Number of options exercised/expired/cancelled | shares	0
Number of options outstanding, ending | shares	6,000,000
Number of options exercisable | shares	1,250,000
Weighted average exercise price outstanding, beginning | $ / shares	$ 0
Weighted average exercise price granted | $ / shares	10.55
Weighted average exercise price exercised/expired/cancelled | $ / shares	0
Weighted average exercise price outstanding, ending | $ / shares	10.55
Weighted average exercise price exercisable | $ / shares	$ 10.55

Common Stock Warrants and Opt_7

Common Stock Warrants and Options (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Warrants expired		572,000
Stock option expense	$ 22,770,662	$ 21,201,397

Income Tax (Details)

Income Tax (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Net operating loss carryforwards	$ 59,276,171	$ 31,276,171
Net deferred tax assets before valuation allowance	59,276,171	31,276,171
Less: Valuation allowance	(59,276,171)	(31,276,171)
Net deferred tax assets	$ 0	$ 0